Overview
Investor fact sheet
News
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2024 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2024 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2023 Health for Humanity Report
2023 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Go to jnj.com
Skip to main content
Latest news
Our company
Careers
Investors
Media center
SEC filings
Overview
Investor fact sheet
News
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2024 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2024 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2023 Health for Humanity Report
2023 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Go to jnj.com
Selecting the value will change the page content
SEC Filings Options
Select Year:
Filter filing type:
All form types
Annual filings
Quarterly filings
Current reports
Proxy filings
Registration statements
Section 16 filings
Other
Date
Filing type
Filing description
Download / view
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com